BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3824496)

  • 1. Evidence for a lymphocyte activation determinant coded by the HLA region different from HLA-DR, DQ, and DP.
    Eiermann TH; Martin A; Wölpl A; Goldmann SF
    Transplant Proc; 1987 Feb; 19(1 Pt 1):866-9. PubMed ID: 3824496
    [No Abstract]   [Full Text] [Related]  

  • 2. [Organization of the chromosomic region of the major human histocompatibility complex].
    Vernet C; Sidibé I; Pontarotti P
    Pathol Biol (Paris); 1992 Oct; 40(8):822-30. PubMed ID: 1484743
    [No Abstract]   [Full Text] [Related]  

  • 3. HLA class II (DR, DQ, DP) in patients with sarcoidosis: evidence of an increased frequency of DRw6.
    Odum N; Milman N; Jakobsen BK; Georgsen J; Svejgaard A
    Exp Clin Immunogenet; 1991; 8(4):227-32. PubMed ID: 1817566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification with the monoclonal antibody 26.163 of a determinant shared by the beta chains of the gene products of the HLA-DR, DQ, and DP loci.
    Igarashi M; Gebhard DH; Chen YX; Safai B; Evans RL; Ferrone S
    Hum Immunol; 1986 Aug; 16(4):347-55. PubMed ID: 2428781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a specific post-transcriptional mechanism controlling the expression of HLA-DQ, but not -DR and -DP, molecules.
    De Lerma Barbaro A; Sartoris S; Tosi G; Nicolis M; Accolla RS
    J Immunol; 1994 Nov; 153(10):4530-8. PubMed ID: 7525708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular organization of the class II genes of the human and mouse major histocompatibility complexes.
    Carson S; Trowsdale J
    Oxf Surv Eukaryot Genes; 1986; 3():63-94. PubMed ID: 2855304
    [No Abstract]   [Full Text] [Related]  

  • 7. MHC gene polymorphism in primary IgA nephropathy.
    Moore R
    Kidney Int Suppl; 1993 Jan; 39():S9-12. PubMed ID: 8468933
    [No Abstract]   [Full Text] [Related]  

  • 8. HLA-DR, DQ, and DX alpha RFLPs and their associations with serologically defined HLA-DR and -DQ antigens.
    Awad J; Navarrete C; Sachs JA; Festenstein H; Cassell PG; Niven MJ; Hitman G
    Immunogenetics; 1988; 27(1):73-6. PubMed ID: 2890578
    [No Abstract]   [Full Text] [Related]  

  • 9. Major histocompatibility complex class II haplotypes and linkage disequilibrium values observed in the CEPH families.
    Carrington M; Stephens JC; Klitz W; Begovich AB; Erlich HA; Mann D
    Hum Immunol; 1994 Nov; 41(3):234-40. PubMed ID: 7868379
    [No Abstract]   [Full Text] [Related]  

  • 10. Lack of evidence of a significant association between HLA-DR, DQ and DP genotypes and atopy in families with HDM allergy.
    Holloway JW; Doull I; Begishvili B; Beasley R; Holgate ST; Howell WM
    Clin Exp Allergy; 1996 Oct; 26(10):1142-9. PubMed ID: 8911699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA class II region sequences, 1998.
    Marsh SG
    Tissue Antigens; 1998 Apr; 51(4 Pt 2):467-507. PubMed ID: 9583802
    [No Abstract]   [Full Text] [Related]  

  • 12. HLA-DR, DRw52.53, and DQ homozygosity in patients with neural tube defects.
    Wong AC; Aoki K; Yagami Y; Akaza T; Takeuchi S; Matsunaga T
    Jinrui Idengaku Zasshi; 1987 Dec; 32(4):319-27. PubMed ID: 3454379
    [No Abstract]   [Full Text] [Related]  

  • 13. The distribution and differential expression of MHC class II antigens (HLA-DR, DP, and DQ) in human fetal adrenal, pancreas, thyroid, and gut.
    Oliver AM; Sewell HF; Abramovich DR; Thomson AW
    Transplant Proc; 1989 Feb; 21(1 Pt 1):651-2. PubMed ID: 2495628
    [No Abstract]   [Full Text] [Related]  

  • 14. HLA class II mRNA accumulation by activated human T cells following growth in conditioned medium.
    Gansbacher B; Zier KS
    Clin Exp Immunol; 1989 Jun; 76(3):440-5. PubMed ID: 2546703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-D region antigens on isolated human colonic epithelial cells: enhanced expression in inflammatory bowel disease and in vitro induction by different stimuli.
    Pallone F; Fais S; Capobianchi MR
    Clin Exp Immunol; 1988 Oct; 74(1):75-9. PubMed ID: 3146453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behçet's disease and major histocompatibility complex class II antigens in Tunisians.
    Hamza M; Ayed K; Hamzaoui K; Bardi R
    Dis Markers; 1988; 6(4):263-7. PubMed ID: 3233881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association with HLA-DR, -DQ or -DP alleles in Guillain-Barré syndrome.
    Hillert J; Osterman PO; Olerup O
    J Neuroimmunol; 1991 Jan; 31(1):67-72. PubMed ID: 1984036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of HLA-D gene products in the normal and coeliac small bowel.
    Kelly J; Weir DG; Feighery C
    Tissue Antigens; 1988 Mar; 31(3):151-60. PubMed ID: 3376099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DP, HLA-DQ, and HLA-DR have different requirements for invariant chain and HLA-DM.
    van Lith M; McEwen-Smith RM; Benham AM
    J Biol Chem; 2010 Dec; 285(52):40800-8. PubMed ID: 20959457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of HLA-DR, DQ and DP loci on monocytes using monoclonal antibodies].
    Májský A
    Cas Lek Cesk; 1987 Oct; 126(42):1313-6. PubMed ID: 3677160
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.